01 · The Question
What exactly counts as an adverse event in research?
A participant develops a headache after a study visit. Another becomes dizzy during a procedure. A laboratory test returns an abnormal result. Someone enrolled in a behavioral study experiences significant psychological distress. Are these adverse events, even if nobody yet knows whether the research caused them?
The term adverse event , often abbreviated as AE , can be confusing because “adverse” sounds as though the research must have harmed the participant. That is not what the term necessarily means. In commonly used research-safety frameworks, identifying an adverse event and deciding what caused it are separate questions.
There is also no single definition that applies identically across every research setting. The U.S. Office for Human Research Protections (OHRP), for example, notes that the HHS human-subject regulations do not define or use the term and that definitions differ among government and non-government entities. Researchers therefore need to understand both the general concept and the specific definition governing their study.
02 · The Short Answer
An adverse event is an occurrence, not a conclusion about causation
In Brief
An adverse event is generally an untoward or unfavorable medical occurrence in a research participant that is temporally associated with research participation or, under some regulatory frameworks, use of an investigational product. Calling something an adverse event does not by itself mean that the research caused it.
The applicable definition depends on the study and regulatory framework. An AE may include a new symptom, disease, abnormal clinical finding, or psychological harm, and further assessment is needed to determine its seriousness, expectedness, relationship to the research, and any reporting obligations.
03 · What You Need to Know
How adverse events are identified and understood
The definition is deliberately broader than “side effect”
OHRP uses adverse event broadly to mean an untoward or unfavorable medical occurrence in a human subject, including an abnormal sign, symptom, or disease, that is temporally associated with research participation, whether or not it is considered related to that participation. OHRP further explains that adverse events can encompass physical and psychological harms.
This means that an AE is not limited to a participant saying, “I had a side effect.” A researcher might identify an event through a participant's report, clinical examination, laboratory result, observation, medical record, or another source specified by the study's safety-monitoring procedures.
For clinical trials involving investigational products, the applicable wording may be narrower. ICH E6(R3), for example, defines an adverse event as an unfavorable medical occurrence in a trial participant who has been administered the investigational product and explicitly states that the event does not necessarily have a causal relationship with the treatment.
Adverse event
Describes an unfavorable occurrence meeting the applicable study or regulatory definition. Causation is not automatically established.
Research-related event
Adds a judgment about whether there is evidence or a reasonable possibility that participation, a research procedure, or an investigational product contributed to the event.
Temporal association is not the same as causation
The word temporally matters. It means that the event occurred during a relevant period associated with participation or exposure. It does not mean that one event caused the other.
Suppose a participant develops influenza while enrolled in a six-month clinical study. Depending on the protocol and applicable definition, the illness may be captured as an adverse event even if there is no plausible connection to the intervention. Classification as an AE can therefore be the beginning of a safety assessment rather than its conclusion.
This is why researchers should not exclude an event simply because they initially believe it is unrelated. Whether an AE must have been caused by the research, and how causality affects subsequent obligations, requires a separate assessment of causality and reporting .
An adverse event can be a sign, symptom, disease, or abnormal finding
An AE does not have to be a formally diagnosed disease. Depending on the governing definition and study protocol, it may appear as an unfavorable sign or symptom, such as dizziness, rash, nausea, pain, or clinically relevant psychological distress. It may also appear as an abnormal physical examination or laboratory finding. OHRP expressly includes abnormal signs, symptoms, and diseases within its broad definition.
Whether every abnormal measurement should be recorded as an AE is more study-specific. Protocols and safety-monitoring plans may define when an abnormal laboratory value becomes an AE, for example because it is clinically significant, represents a new condition, worsens from baseline, or requires intervention. Researchers should therefore use the protocol's operational definition rather than assuming that every value outside a laboratory reference range automatically constitutes a separate AE.
A worsening pre-existing condition may become an adverse event
A condition that already existed before participation is not necessarily a new adverse event merely because it remains present during the study. The distinction often becomes important when the condition changes.
Study protocols commonly treat a clinically meaningful worsening of a pre-existing condition as an AE. For example, NIH-supported trial materials have distinguished unchanged pre-existing conditions from conditions that worsen in severity, frequency, or character during the relevant study period. The exact rule, however, should come from the protocol and applicable safety framework rather than from a generic definition alone.
Adverse events are not confined to drug trials
The terminology is strongly associated with clinical trials, but participant harm is not exclusively pharmacological. OHRP notes that adverse events encompass physical and psychological harms and may occasionally occur in social and behavioral research as well as biomedical research.
For example, research procedures involving traumatic experiences may be associated with psychological distress. Whether a particular episode satisfies the study's formal AE definition will depend on the applicable protocol and oversight framework. Regardless of terminology, researchers conducting sensitive studies should have procedures for responding to unexpected participant distress rather than waiting to debate labels while a participant needs assistance.
Several different questions come after identifying an AE
Once an event has been identified, researchers may need to characterize it along several dimensions. These dimensions should not be collapsed into a single judgment.
Question
What it asks
Why it is different
Is it an adverse event?
Does the occurrence meet the applicable AE definition?
This identifies the event.
Is it serious?
Does it meet specified seriousness criteria?
Seriousness is a classification, not another word for severity.
Is it related?
Could the research intervention or procedures have caused or contributed to it?
This addresses causality.
Is it expected?
Is its nature or severity consistent with relevant risk information and the applicable framework?
This addresses whether the event was anticipated.
Is it reportable?
Do the applicable protocol, IRB or REC, sponsor, funder, or regulatory requirements require notification?
Not every AE necessarily follows the same reporting pathway or timeline.
These distinctions matter because an event can occupy different combinations of categories. An event may be unrelated but serious, related but non-serious, expected or unexpected, and subject to different reporting requirements. The question of what makes an adverse event serious therefore needs to be assessed separately from whether an AE occurred at all.
An adverse event is not automatically an unanticipated problem
In the OHRP framework, adverse event and unanticipated problem are overlapping but different concepts. OHRP considers an unanticipated problem to involve an incident, experience, or outcome that is unexpected, related or possibly related to the research, and suggests that the research places participants or others at greater risk of harm than was previously known or recognized. Some unanticipated problems do not involve an adverse event at all.
Researchers should therefore avoid using the two labels interchangeably. The distinction between an unanticipated problem and an adverse event can determine how a safety occurrence is evaluated and handled.
Watch Out
Do not use the phrase “adverse event” as proof that the research caused harm. Recording an occurrence as an AE and assessing its relationship to the research are separate steps. FDA's current IND terminology likewise distinguishes an adverse event from a suspected adverse reaction, for which there must be evidence suggesting a causal relationship with the drug.
04 · A Practical Example
A participant develops dizziness during a research study
Hypothetical Example
The event is recorded before causality is settled
A participant in a clinical research study reports a new episode of dizziness two days after a study intervention. The symptom was not present at baseline. The research team does not yet know whether it was caused by the intervention, another medication, dehydration, an unrelated illness, or something else.
Occurrence
The participant experiences a new unfavorable symptom during the relevant study period.
Identification
Under the hypothetical protocol's AE definition, the new symptom meets the criteria for an adverse event.
Documentation
The team records the event and the information required by the protocol, such as onset, severity, duration, outcome, and relevant clinical details.
Assessment
The appropriate investigator assesses seriousness, expectedness, and whether the event may be related to the research.
Action
The team follows the protocol and applicable institutional, sponsor, and regulatory requirements for management, follow-up, and any required reporting.
The important point is that the team does not need to prove that the intervention caused the dizziness before recognizing the occurrence as an AE under this hypothetical protocol. Nor does the label itself prove causation. The appropriate person must subsequently assess whether the event is related to the research .
06 · What This Means for You
What to do when something unfavorable happens to a participant
When you learn that a participant has experienced an unfavorable medical or psychological occurrence, avoid making the first decision based solely on whether you think the research caused it. Start with the definition and procedures specified for your study.
A simple decision framework
If an unfavorable occurrence happens during the relevant research period
Check whether it meets the AE definition in the protocol, safety-monitoring plan, and applicable regulatory or institutional requirements.
If it meets the AE definition
Document the information required by the study and ensure that immediate participant care or safety needs are addressed.
If the event may be medically important or serious
Follow the study's escalation procedures promptly rather than waiting for every detail or causal question to be resolved.
If causality is uncertain
Do not convert uncertainty into “unrelated” by default. Have relatedness assessed according to the study's defined process.
If you are unsure whether or when the event must be reported
Consult the protocol and the requirements of the relevant IRB or REC, sponsor, funder, and regulator rather than assuming that all AEs have the same reporting rule.
If a participant becomes acutely ill or injured, classification and paperwork should not displace appropriate attention to the participant's immediate welfare. Researchers should follow the study's emergency and safety procedures for illness or injury occurring during research , then complete the necessary assessment and documentation.
07 · A Quick Checklist
Before deciding how to classify a participant-safety event
When a possible adverse event occurs, check:
Read the exact AE definition in the approved protocol and safety-monitoring plan.
Determine what happened, when it began, and whether it is new or represents a change from baseline.
Document relevant signs, symptoms, diagnoses, laboratory findings, or psychological effects as required by the study.
Do not reject an event as an AE solely because its relationship to the research is uncertain or appears unlikely.
Assess seriousness using the criteria applicable to the study rather than using “serious” as a synonym for “severe.”
Have relatedness and expectedness assessed according to the protocol and applicable oversight requirements.
Verify reporting requirements and deadlines with the applicable IRB or REC, sponsor, funder, and regulator.
Prioritize necessary participant care and immediate safety actions when the event requires intervention.
09 · The Bottom Line
Recognize the event first, then determine what it means
The Bottom Line
An adverse event is an unfavorable occurrence meeting the applicable research-safety definition, and identifying one does not by itself mean that the research caused it.
Once a possible AE is identified, determine what the study requires you to document and assess, including seriousness, expectedness, relatedness, and reporting obligations. Keeping those questions separate makes participant-safety decisions more accurate and helps prevent both under-recognition and unnecessary causal assumptions.
11 · Cite this Guide
How to Cite This Guide
This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.
Recommended (Field Guide)
APA
MLA
Chicago
Copy Citation